BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX).
About the Investigation
On January 10, 2025, Bloomberg reported TransMedics shares dropped “as much as 13% after Scorpion Capital said it is short the transplant-therapy company’s stock.”
Contact
If you have information concerning Scorpion Capital’s report or would like more information about our investigation, please click here: Shareholder Contact | Berman Tabacco or contact us at 800-516-9926 or law@bermantabacco.com.
About Berman Tabacco
Since 1982, our firm has prosecuted hundreds of securities and antitrust complex cases. The firm and its attorneys have been recognized for their work on behalf of plaintiffs, including by Chambers USA, Benchmark Litigation, which has ranked the firm as Highly Recommended and a Top Ten Plaintiffs, The Legal 500, U.S. News & World Report-Best Lawyers, The Daily Journal, Lawdragon, Who’s Who Legal, and Super Lawyers. The firm has offices in Boston, Massachusetts and San Francisco, California.
For more information, click here or contact us at 800-516-9926 or law@bermantabacco.com.
This notice may constitute attorney advertising.
Past results do not guarantee future outcomes.
Jay Eng, Esq.
Berman Tabacco
One Liberty Square
Boston, Massachusetts
(800) 516-9926
Email: law@bermantabacco.com
